Concurrent fatty liver increases risk of hepatocellular carcinoma among patients with chronic hepatitis B-Reference-Cited by-同舟云学术

Concurrent fatty liver increases risk of hepatocellular carcinoma among patients with chronic hepatitis B

Published:2017-03 Issue:3 Volume:32 Page:667-676
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:Journal of Gastroenterology and Hepatology

Author:

Chan Anthony W H¹²^ORCID,Wong Grace L H³⁴⁵,Chan Hoi-Yun³⁴⁵,Tong Joanna H M¹²,Yu Yau-Hei¹²,Choi Paul C L¹,Chan Henry L Y³⁴⁵,To Ka-Fai¹²⁴⁵,Wong Vincent W S³⁴⁵

Affiliation:

1. Department of Anatomical and Cellular Pathology; The Chinese University of Hong Kong; Hong Kong

2. Li Ka Shing Institute of Health Science, Sir Y. K. Pao Cancer Center; The Chinese University of Hong Kong; Hong Kong

3. Department of Medicine and Therapeutics; The Chinese University of Hong Kong; Hong Kong

4. Institute of Digestive Disease, Partner State Key Laboratory of Digestive Disease; The Chinese University of Hong Kong; Hong Kong

5. State Key Laboratory of Digestive Disease; The Chinese University of Hong Kong; Hong Kong

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jgh.13536/fullpdf

Reference42 articles.

1. Ferlay J Soerjomataram I Ervik M et al GLOBOCAN 2012 v1.0

2. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013;Schweitzer;Lancet,2015

3. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma;European Association for the Study of the Liver, European Organisation For Research and Treatment of Cancer;J. Hepatol.,2012

4. Asia Pacific working party on prevention of hepatocellular C. Hepatocellular carcinoma in the Asia Pacific region;Yuen;J. Gastroenterol. Hepatol.,2009

5. Hepatitis B virus infection;Trepo;Lancet,2014

Cited by 148 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NAFLD is associated with less severe liver fibrosis in chronic hepatitis B: A multi-center, retrospective study;Annals of Hepatology;2024-01

2. Harnessing the power of hepatitis B screening programmes: the I REACH OUT model;The Lancet Gastroenterology & Hepatology;2024-01

3. Fatty Liver Disease;MacSween's Pathology of the Liver;2024

4. Integrated investigation and experimental validation of PPARG as an oncogenic driver: implications for prognostic assessment and therapeutic targeting in hepatocellular carcinoma;Frontiers in Pharmacology;2023-11-15

5. Low liver fat in non‐alcoholic steatohepatitis‐related significant fibrosis and cirrhosis is associated with hepatocellular carcinoma, decompensation and mortality;Alimentary Pharmacology & Therapeutics;2023-11-15